Economic analysis of rotavirus-associated diarrhea in the metropolitan Toronto and Peel regions of Ontario

Canadian Journal of Infectious Diseases

Volumn 13, Issue 3, 2002, Pages 167-174

  Jacobs, P ^a   Shane, L G ^a   Fassbender, K ^a   Wang, E L ^a   Moineddin, R ^a   Ford Jones, E L ^a  

^a INSTITUTE OF HEALTH ECONOMICS   (Canada)

Author keywords

Cost; Cost analysis; Rotavirus

Indexed keywords

ANTIDIARRHEAL AGENT;

ABSENTEEISM; AGE DISTRIBUTION; ARTICLE; CANADA; CHILD; CONTROLLED STUDY; COST BENEFIT ANALYSIS; DIARRHEA; DRUG COST; GEOGRAPHIC DISTRIBUTION; HEALTH CARE COST; HEALTH ECONOMICS; HEALTH SERVICE; HOSPITALIZATION; HUMAN; INFANT; MAJOR CLINICAL STUDY; PRESCRIPTION; REGRESSION ANALYSIS; ROTAVIRUS; SEROPREVALENCE; SOCIOECONOMICS;

EID: 0036332777     PISSN: 11802332     EISSN: None     Source Type: Journal    
DOI: 10.1155/2002/926349     Document Type: Article

References (13)

1. Rotavirus disease in Finnish children: Use of numerical scores for clinical severity of diarrhoeal episodes
2. Epidemiology of diarrheal disease among children enrolled in four west coast health maintenance organizations
3. Economic impact of immunization against rotavirus gastroenteritis
4. Economic evaluation of rotavirus vaccinations in Finland: Randomized, double-blind, placebo-controlled trial of tetravalent rhesus rotavirus vaccine
5. Hospitalization for community-acquired, rotavirus-associated diarrhea
6. Rotavirus-associated diarrhea in outpatient settings and child care centers
7. Etiology of community acquired viral diarrhea